Cardiome Pharma Corp. is a listed company. Its directors and officers file their transactions with SEDI. Cardiome Pharma Corp. has had no insider filing for more than a year; the last one goes back to 25 May 2018.
Looking back to 2016, when coverage begins, insiders filed 17 purchases and 12 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 71 declarations
Cardiome Pharma Corp. is a biopharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.